Travis WD, Costabel U, Hansell DM, King TE, Lynch DA, Nicholson AG et al (2013) An official American Thoracic Society/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188(6):733–748
Article PubMed PubMed Central Google Scholar
Raghu G, Remy-Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T et al (2022) Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: An official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med 205(9):e18–e47
Article PubMed PubMed Central Google Scholar
Flaherty KR, Wells AU, Cottin V, Devaraj A, Walsh SLF, Inoue Y et al (2019) Nintedanib in progressive fibrosing interstitial lung diseases. N Engl J Med 381(18):1718–1727
Article CAS PubMed Google Scholar
Ley B, Bradford WZ, Vittinghoff E, Weycker D, du Bois RM, Collard HR (2016) Predictors of mortality poorly predict common measures of disease progression in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 194(6):711–718
Article PubMed PubMed Central Google Scholar
Oldham JM, Lee CT, Wu Z, Bowman WS, Pugashetti JV, Dao N, Tonkin J, Seede H, Echt G, Adegunsoye A, Chua F, Maher TM, Garcia CK, Strek ME, Newton CA, Molyneaux PL (2022) Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J 59(6):2101396. https://doi.org/10.1183/13993003.01396-2021
Article CAS PubMed PubMed Central Google Scholar
Hoffmann-Vold AM, Brunborg C, Airò P, Ananyeva LP, Czirják L, Guiducci S, Hachulla E, Li M, Mihai C, Riemekasten G, Sfikakis PP, Valentini G, Kowal-Bielecka O, Allanore Y, Distler O, EUSTAR Collaborators (2023) Cohort enrichment strategies for progressive interstitial lung disease in systemic sclerosis from European Scleroderma trials and research. Chest 163(3):586–598. https://doi.org/10.1016/j.chest.2022.09.044. Epub 2022 Oct 14
Wang BR, Edwards R, Freiheit EA, Ma Y, Burg C, de Andrade J et al (2020) The pulmonary fibrosis foundation patient registry. Rationale, design, and methods. Ann Am Thorac Soc 17(12):1620–1628
Dressen A, Abbas AR, Cabanski C, Reeder J, Ramalingam TR, Neighbors M et al (2018) Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. Lancet Respir Med 6(8):603–614
Article CAS PubMed PubMed Central Google Scholar
Newton CA, Oldham JM, Ley B, Anand V, Adegunsoye A, Liu G et al (2019) Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J 53(4):1801641
Greene KE, King TE, Kuroki Y, Bucher-Bartelson B, Hunninghake GW, Newman LS et al (2002) Serum surfactant proteins-A and -D as biomarkers in idiopathic pulmonary fibrosis. Eur Respir J 19(3):439–446
Article CAS PubMed Google Scholar
Manichaikul A, Sun L, Borczuk AC, Onengut-Gumuscu S, Farber EA, Mathai SK et al (2017) Plasma soluble receptor for advanced glycation end products in idiopathic pulmonary fibrosis. Ann Am Thorac Soc 14(5):628–635
Article PubMed PubMed Central Google Scholar
Gao X, Jia G, Guttman A, DePianto DJ, Morshead KB, Sun KH et al (2020) Osteopontin links myeloid activation and disease progression in systemic sclerosis. Cell Rep Med 1(8):100140
Article CAS PubMed PubMed Central Google Scholar
Neighbors M, Cabanski CR, Ramalingam TR, Sheng XR, Tew GW, Gu C et al (2018) Prognostic and predictive biomarkers for patients with idiopathic pulmonary fibrosis treated with pirfenidone: post-hoc assessment of the CAPACITY and ASCEND trials. Lancet Respir Med 6(8):615–626
Organ LA, Duggan AR, Oballa E, Taggart SC, Simpson JK, Kang’ombe AR et al (2019) Biomarkers of collagen synthesis predict progression in the PROFILE idiopathic pulmonary fibrosis cohort. Respir Res 20(1):148
Article PubMed PubMed Central Google Scholar
Dobrota R, Jordan S, Juhl P, Maurer B, Wildi L, Bay-Jensen A-C, Asser Karsdal M, Herrick AL, Distler JHW, Allanore Y, Hoffmann-Vold A-M, Sofie Siebuhr A, Distler O (2021) Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study. Lancet Rheumatol 3(3):e175-e184, ISSN 2665–9913.
Comments (0)